QT Imaging Holdings, Inc. (QTI)
NASDAQ: QTI · Real-Time Price · USD
6.52
-0.08 (-1.21%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Company Description
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems with low frequency sound waves for detection, diagnosis, and treatment of diseases in the United States and Internationally.
The company offers QT Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast.
It serves patients, medical professionals, and radiologists. The company has a collaboration with Olea Medical S.A.S for the development of QTI Imaging-Olea Viewer; and a strategic partnership with Intelerad Medical Systems Incorporated.
QT Imaging Holdings, Inc. was founded in 2012 and is headquartered in Novato, California.
QT Imaging Holdings, Inc.
| Country | United States |
| Founded | 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 32 |
| CEO | Raluca Dinu |
Contact Details
Address: 3 Hamilton Landing, Suite 160 Novato, California 94949 United States | |
| Phone | 650 276 7040 |
| Website | qtimaging.com |
Stock Details
| Ticker Symbol | QTI |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001844505 |
| CUSIP Number | 746962109 |
| ISIN Number | US7469623075 |
| Employer ID | 86-1728920 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Dr. Raluca Dinu Ph.D. | Chief Executive Officer and Director |
| Jay W. Jennings CPA | Chief Financial Officer |
| Steve Choate | Chief Operating Officer |
| Dr. Bilal Malik Ph.D. | Chief Science Officer |
| Nasser C. Pirshafiey M.B.A. | Chief Product Officer |
| Dr. Elaine Iuanow M.D. | Chief Medical Officer |
| Satrajit Misra | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2026 | EFFECT | Notice of Effectiveness |
| Mar 31, 2026 | EFFECT | Notice of Effectiveness |
| Mar 31, 2026 | EFFECT | Notice of Effectiveness |
| Mar 31, 2026 | EFFECT | Notice of Effectiveness |
| Mar 27, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Mar 25, 2026 | 8-K | Current Report |
| Mar 25, 2026 | POS AM | Post-Effective amendments for registration statement |
| Mar 25, 2026 | POS AM | Post-Effective amendments for registration statement |
| Mar 25, 2026 | POS AM | Post-Effective amendments for registration statement |
| Mar 25, 2026 | 8-K | Current Report |